Abstract
Our aim was to detect markers of Chlamydia pneumoniae (CPN) and human cytomegalovirus (HCMV) infection in patients with peripheral vascular occlusive disease and to follow markers of inflammation, endothelial dysfunction and lipid metabolism alteration in patients with active infection. CPN genome was detected in 9 (47.4 %) patients by at least one PCR method. Serological markers of acute CPN infection were found in 5 (26.3 %) subjects; each of them showed also positivity in at least one of the PCR methods. HCMV DNA were detected in 2 (10.5 %) patients; HCMV-specific antibodies were detected in 14 (73.7 %) subjects, however only in IgG subclass. Subjects with HCMV PCR positivity thus showed no serological markers of active HCMV infection. Laboratory findings of acute CPN infection were associated with increased plasma levels of Lp(a), triacylglycerols, atherogenic index of plasma and E-selectin (p < 0.05). No significant differences were found in the other markers, including plasma levels of total cholesterol, ferritin, homocysteine, oxidized LDL, IL-6, IL-8, IL-18, TNF-α, soluble forms of VCAM-1 and ICAM-1, von Willebrand factor, C-reactive protein, and plasma nitrites & nitrates. Frequent presence of chlamydial DNA in atheromatous plaques from patients with peripheral vascular disease was confirmed. HCMV DNA was detected only sporadically and with positivity in anamnestic anti-HCMV antibodies (IgG) only, indicating a rare presence of latent virus rather than active replication. Patients with laboratory markers of acute CPN infection exhibited more pronounced alterations in lipid metabolism and endothelial dysfunction.
Similar content being viewed by others
Abbreviations
- ABI:
-
ankle-brachial index
- AIP:
-
atherogenic index of plasma
- ALT:
-
alanine aminotransferase
- AST:
-
aspartate aminotransferase
- CHS:
-
cholesterol
- CPN:
-
Chlamydia pneumoniae
- DSA:
-
digital subtraction angiography
- HCMV:
-
human cytomegalovirus
- HDL:
-
high density lipoprotein
- HOMA-IR:
-
homeostatic model assessment
- hsCRP:
-
high sensitivity C-reactive protein
- ICAM:
-
intercellular adhesion molecule
- IL:
-
interleukin
- LDL:
-
low density lipoprotein
- LPS:
-
lipopolysaccharide
- MIF:
-
microimmunofluorescence
- MOMP:
-
major outer membrane protein
- PCR:
-
polymerase chain reaction
- TGs:
-
triacylglycerols
- TNF-α:
-
tumor necrosis factor α
- VCAM:
-
vascular cell adhesion molecule-1
- vWf:
-
von Willebrand factor
References
Apfalter P., Blasi F., Boman J., Gaydos C.A., Kundi M., Maass M., Makristathis A., Meijer A., Nadrchal R., Persson K., Rotter M.L., Tong C.Y.W., Stanek G., Hirschl A.M.: Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J.Clin.Microbiol. 39, 519–524 (2001).
Apfalter P., Assidian O., Blasi F., Boman J., Gaydosh C., Kundi M., Makristathis A., Nehr M., Rotter M.L., Hirschl A.M.: Reliability of nested PCR for detection of Chlamydia pneumoniae in atheromas: results from multicenter study applying standardized protocols. J.Clin.Microbiol. 40, 4428–4434 (2002).
Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., Capeau J., Feve B.: Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur.Cytokine Netw. 17, 4–12 (2006).
Bulvas M., Urbanová R., Klezlová R., Vítková I.: Markedly eccentric peripheral vascular stenoses: percutaneous atherectomy with an endomyocardial biopsy device. Radiology 217, 587–592 (2000).
Campbell L.A., O’Brien E.R., Cappuccio A.L., Kuo C.C., Wang S.P., Stewart D., Patton D.L., Cummings P.K., Grayston J.T.: Detection of Chlamydia pneumoniae (TWAR) in human coronary artherectomy tissues. J.Infect.Dis. 172, 858–588 (1995).
Cochrane M., Pospischil A., Walker P., Gibbs H., Timms P.: Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures. J.Clin.Microbiol. 41, 1454–1457 (2003).
Crkovská J., Štípek S.: Factors influencing the determination of serum nitrite and nitrate using nitrate reductase and Griess reagent. Klin.Biochem.Metab. 6, 82–87 (1998).
Dahlén G.H.: Lipoprotein(a) as a risk factor atherosclerotic diseases. Arctic Med.Res. 47(Suppl. I), 458–641 (1988).
Danesh J., Collins R., Peto R.: Chronic infections and coronary heart disease: is there a link? Lancet 350, 430–436 (1997).
Davidson M., Kuo C.C., Middaugh J.P., Campbell L.A., Wang S.P., Newman W.P. 3rd, Finley J.C., Grayston J.T.: Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 98, 628–633 (1998).
Dobiášova M., Frohlich J.: The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB lipoprotein-depleted plasma (FER/HDL). Clin.Biochem. 34, 583–588 (2001).
Dowell S.F., Peeling R.W., Boman J., Carlone G.M., Fields B.S., Guarner J., Hammerschlag M.R., Jackson L.A., Kuo C.C., Maass M., Messmer T.O., Talkington D.F., Tondella M.L., Zaki S.R.: Standardizing Chlamydia pneumoniae assays: recomendations from the centers for disease control and prevention (USA) and the laboratory centre for disease control (Canada). Clin.Infect.Dis. 33, 492–450 (2001).
Fernandez-real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., Ricart W.: Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J.Clin.Endocrinol.Metab. 86, 1154–1159 (2001).
Gieffers J., Durling L., Ouellette S.P., Rupp J., Maass M., Byrne G.I., Caldwell H.D., Belland R.J.: Genotypic differences in the Chlamydia pneumoniae tyrP locus related to vascular tropism and pathogenicity. J.Infect.Dis. 188, 1085–1093 (2003).
Glader C.A., Boman J., Saikku P., Stenlund H., Weinehall L., Hallmanns G., Dahlén G.H.: The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniaespecific IgG antibodies. Eur.Heart J. 21, 639–646 (2000).
Grayston T.: Background of current knowledge of Chlamydia pneumoniae and atherosclerosis. J.Infect.Dis. 181(Suppl. 3), S402–S410 (2000).
Heinsohn S., Golta S., Kabisch H., Zur Stadt U.: Standardized detection of Simian virus 40 by real-time quantitative polymerase chain reaction in pediatric malignancies. Haematologica 90, 94–98 (2005).
Hrubá D., Roubalová K., Kraml P., Anděl M.: Examination of the manifastation of Chlamydia pneumoniae active infection at patients with heart ischemia. (In Czech) Čas.Lék.Čes. 143, 830–835 (2004).
Ibrahim A.I., Obeid M.T., Jouma M.J., Moasis G.A., Al-richane W.L., Kindermann I., Boehm M., Roemer K., Muellerlantzsch N., Gärtner B.C.: Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J.Clin.Virol. 32, 29–32 (2005).
Jackson L.A., Campbell L.A., Schmidt R.A., Kuo C.C., Cappuccio A.L., Lee M.J., Grayston J.T.: Specificity of detection of Chlamydia pneumoniae in cardiovascular artheroma: evaluation of inocent bystader hypothesis. Am.J.Pathol. 150, 1785–1790 (1997).
Kaukoranta-Tolvanen S.S., Ronni T., Leinonen M.: Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb.Pathog. 21, 407–411 (1996).
Kostner G.M., Avogaro P., Cazzolato G., Marth E., Bittolo-Bon G., Quinici G.B.: Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38, 51–61 (1981).
Kuo C.C., Gown A., Benditt E., Grayston T.: Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arteioscler.Tromb. 13, 1501–1504 (1993a).
Kuo C.C., Shor A., Campbell L.A., Fukushi H., Patton D.L., Grayston J.T.: Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J.Infect.Dis. 167, 841–849 (1993b).
Kuo C.C., Grayston J.T., Campbell L.A., Goo Y.A., Wissler R.W., Benditt E.P.: Chlamydia pnumoniae (TWAR) in coronary arteries of young adults (15 to 35 years old). Proc.Soc.Acad.Sci.USA 92, 6911–6914 (1995).
Kuo C.C., Coulson A.S., Campbell L.A., Cappuccio A.L., Wang S.P., Grayston J.T.: Detection of Chlamydia pneumoniae in atherosclerotic plaques in walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J.Vasc.Surg. 26, 29–31 (1997).
Kuo C.C., Campbell L.A.: Detection of Chlamydia pneumoniae in arterial tissues. J.Infect.Dis. 181(Suppl. 3), S432–S436 (2000).
Laurila A., Bloigu A., Näyhä S., Hassi J., Leinonen M., Saikku P.: Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arter.Thromb.Vasc.Biol. 17, 2910–2913 (1997).
Levy J.C., Matthews D.R., Hermans M.P.: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21, 2191–2192 (1998).
Liu R., Moroi M., Yamamoto M., Kubota T., Ono T., Funatsu A., Komatsu H., Tsuji T., Hara H., Nakamura M., Hirai H., Yamaguchi T.: Presence and severity of Chlamydia pneumoniae and cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Internat.Heart J. 47, 511–519 (2006).
Maraha B., Berg H., Kerver M., Kranendonk S., Hamming J., Kluytmans J., Peeters M., Van Der Zee A.: Is the perceived association between Chlamydia pneumoniae and vascular diseases biased by methodology? J.Clin.Microbiol. 42, 3937–3941 (2004).
Ramirez J.A.: Chlamydia pneumoniae/atherosclerosis study group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann.Intern.Med. 125, 979–982 (1996).
Rhoads G.G., Dahlén G., Berg K., Morton N.E., Dannenberg A.L.: Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256, 2540–2544 (1986).
Roubalová K.: Concomitant detection of DNA Chlamydia pneumoniae and Chlamydia trachomatis using real-time PCR. Epidemiol. Microbiol.Immunol. 4, 166–176 (2007).
Schäfer P., Braun R.W., Möhring K., Henco K., Kang J., Wendland T., Kühn J.E.: Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested polymerase chain reaction and temperature gradient gel electrophoresis. J.Gen.Virol. 74, 2699–2707 (1993).
Schumacher A., Seljeflot I., Lerkerød A.B., Sommervoll L., Otterstad J.E., Arnesen H.: Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? Clin. Microbiol.Infect. 8, 654–661 (2002).
Shor A., Kuo C.C., Patton D.: Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. South Afr.Med.J. 82, 158–161 (1992).
Tong C.Y.W., Sillis M.: Detection of Chlamydia pneumoniae and Chlamydia psitacii in sputum samples by PCR. J.Clin.Pathol. 46, 313–317 (1993).
Vielma S.A., Mironova M., Ku J.R., Lopes Virella M.F.: Oxidized LDL further enhances expression of adhesion molecules in Chlamydophila pneumoniae-infected endothelial cells. J.Lipid Res. 45, 873–880 (2004).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kraml, P.J., Roubalová, K., Bulvas, M. et al. Markers of Chlamydia pneumoniae and human cytomegalovirus infection in patients with chronic peripheral vascular disease and their relation to inflammation, endothelial dysfunction and changes in lipid metabolism. Folia Microbiol 53, 551–557 (2008). https://doi.org/10.1007/s12223-008-0088-9
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-008-0088-9